RxDoctor Payments Data

Heidi Lyn Stern, MD

Obstetrics & Gynecology · El Paso, TXNPI 1578666053

Payments from drug & device makers

$4,893in general payments, 2019–2025

Across 20 payments — averaging $244.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$5K
  • Organon$68
  • Astellas Pharma US Inc$65
  • Hologic Sales And Service, LLC$63
  • Dexcom, Inc.$47
  • Optumhealth Care Solutions, LLC$22
  • plus $53 from 4 others

What the payments were for

  • Food & beverage$3938%
  • Education$4,50092%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intuitive Surgical5$4,575
Organon3$68
Astellas Pharma US Inc3$65
Hologic Sales And Service, LLC2$63
Dexcom, Inc.2$47
Optumhealth Care Solutions, LLC1$22
Coopersurgical, Inc.1$15
Pfizer1$14
Shield Therapeutics Inc1$14
Meditrina1$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,893 in reported general payments places this provider in the 80th percentile of 3,099 obstetrics & gynecology providers in Texas.

See all obstetrics & gynecology providers in Texas

Medicare billing

Part B allowed, 2024
$17,682
Medicare patients
94
Services billed
212

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PremarinEstrogens, Conjugated33$15,398
Estradiol170$6,884
YuvafemEstradiol12$2,589
ProgesteroneProgesterone, Micronized36$1,379
ValacyclovirValacyclovir Hcl12$971
Bupropion XlBupropion Hcl12$290
Levothyroxine Sodium11$107
Hydrocortisone11$66

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPremarin$14$15,39833 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,099 obstetrics & gynecology providers in Texas.

Other obstetrics & gynecology in El Paso

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →